Concepedia

Tom Cormier

TC

1

Publications

80

Citations

1

H-Index

2009

Active since

Affiliations

National Cancer Institute(Current)

Tom Cormier is an author at National Cancer Institute specializing in pharmacogenomics, drug discovery, and drug development.

Top concepts

Publications per year

2009–2009

1

Publications

1

A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform

John F. Deeken, Tom Cormier, Douglas K. Price et al. · The Pharmacogenomics Journal · 2009 · 80 citations

, , +10

Rows per page

1–1 of 1